DJIA 17,356.87 288.00 1.69%
NASDAQ 4,644.31 96.48 2.12%
S&P 500 2,012.89 40.15 2.04%
market minute promo

Acorda Therapeutics, Inc. (NASDAQ: ACOR)

38.47 0.22 (0.58%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ACOR $38.47 0.58%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $38.25
Previous Close $38.25
Daily Range $38.08 - $39.70
52-Week Range $27.51 - $39.95
Market Cap $1.6B
P/E Ratio 69.55
Dividend (Yield) $0.00 (0.0%)
Volume 640,721
Average Daily Volume 437,790
Current FY EPS $0.45





Acorda Therapeutics, Inc. (ACOR) Description

A commercial-stage biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the CNS. Website:

News & Commentary Rss Feed

3 Companies Growing Faster Than MannKind Corporation

MannKind may be on the precipice of growth surge thanks to Afrezza, but these three biotech stocks are still growing faster than MannKind.

Acorda's Ampyra in Phase III for Post-Stroke Walking Deficit - Analyst Blog

Acorda's Ampyra in Phase III for Post-Stroke Walking Deficit - Analyst Blog

US Stock Futures Up Ahead Of Economic Data

Benzinga's Top Initiations

Goldman Sachs Initiates Acorda Therapeutics With Neutral

Is Acorda Therapeutics (ACOR) Stock a Solid Choice Right Now? - Tale of the Tape

Cynapsus Or Acorda - Whose Market Is It For Parkinson's Disease?

Events for the Week of Nov. 17-21, 2014

ACOR Crosses Below Key Moving Average Level

Acorda Growth Is Expected To Stall

See More ACOR News...

ACOR's Top Competitors

ACOR $38.47 (0.58%)
Current stock: ACOR
AMGN $163.48 (2.53%)
Current stock: AMGN
GILD $102.40 (1.93%)
Current stock: GILD
BIIB $332.89 (2.39%)
Current stock: BIIB